Regeneron Pharmaceuticals, Inc. (REGN)
Tarrytown, NY
Total Compensation for Fiscal Year Ending in 2020: $135,350,121
| Salary | $1,480,119 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $130,000,032 |
| Value of Option Awards | $0 |
| Non-Equity Incentive Plan Compensation | $3,567,714 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $302,256 |
| Total | $135,350,121 |
Regeneron Pharmaceuticals, Inc. disclosed its CEO pay was
933
times its median employee's pay for the fiscal year ending in 2020.
How Do You Compare?
